Showing results (1-10 of 278) with videos related to
Sort By:
Pageof 28
PET Clinics|May 10, 2016
Challenges for Developing PET Tracers: Isotopes, Chemistry, and Regulatory AspectsRobert H Mach, Sally W SchwarzJournal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 19, 2014
New targets for the development of PET tracers for imaging neurodegeneration in Alzheimer diseaseRobert H MachSeminars in Nuclear Medicine|August 23, 2017
Small Molecule Receptor Ligands for PET Studies of the Central Nervous System-Focus on G Protein Coupled ReceptorsRobert H MachEJNMMI Radiopharmacy and Chemistry|October 30, 2019
US and EU radiopharmaceutical diagnostic and therapeutic nonclinical study requirements for clinical trials authorizations and marketing authorizationsSally W Schwarz, Clemens DecristoforoDrug Discovery Today. Technologies|July 4, 2014
Radiopharmacy: regulations and legislations in relation to human applicationsClemens Decristoforo, Sally W SchwarzJournal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 14, 2015
The role of exploratory investigational new drugs for translating radiopharmaceuticals into first-in-human studiesSally W Schwarz, Reiko OyamaJournal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 24, 2014
Diversification in the Supply Chain of (99)Mo Ensures a Future for (99m)TcCathy S Cutler, Sally W SchwarzRadiology. Imaging Cancer|January 28, 2022
The Development of <sup>18</sup>F Fluorthanatrace: A PET Radiotracer for Imaging Poly (ADP-Ribose) Polymerase-1Hsiaoju S Lee, Sally W Schwarz, Erin K Schubert, et al.Progress in Molecular Biology and Translational Science|September 5, 2019
Development of brain PET imaging agents: Strategies for imaging neuroinflammation in Alzheimer's diseaseBieneke Janssen, Robert H MachAdvances in Experimental Medicine and Biology|March 19, 2017
The Evolution of the Sigma-2 (σ<sub>2</sub>) Receptor from Obscure Binding Site to Bona Fide Therapeutic TargetChenbo Zeng, Robert H MachPageof 28